STEPS TAKEN AFTER GRANTING THE MARKETING AUTHORISATION 
For procedures finalised after 4 June 2003 please refer to module 8B.  
Scope 
Application 
number 
Type of 
modification1 
Notification/ 
Opinion issued 
on2 
Extension of the indication 
Addistion of a new pharmaceutical form 
Update of SPC and Package Leaflet 
Change in or addition of manufacturing site(s) for part or all 
of the manufacturing process 
Changes  to  the  the  test  methods  and  specifications  for  the 
active substance 
II/01 
X/02 
II/03 
Ι/04 
II/06 
Commission 
Decision 
Issued/amended 
on 
19.07.02 
16.04.03 
04.06.03 
07.01.03 
II 
Extension 
II 
Ι 
25.04.02 
16.12.02 
20.02.03 
13.12.02 
II 
25.04.03 
30.04.03 
1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers to a 
minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor 
variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II 
application. 
T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 
of 7 November 1996.  
N refers to a notification in accordance with Article 10(3) of Council Directive 92/27/EEC of 31 March 1992. 
2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification 
date. The Commission Decision will be amended accordingly. 
1/1 
EMEA 2005 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                            
 
